Biotech Financial Statements From 2010 to 2025
| BMCS Stock | USD 0.02 0 13.57% |
Check Biotech Medics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotech Medics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Biotech financial statements analysis is a perfect complement when working with Biotech Medics Valuation or Volatility modules.
Biotech |
Biotech Medics Ne Company Shares Outstanding Analysis
Biotech Medics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Biotech Medics Shares Outstanding | 172.36 M |
Most of Biotech Medics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotech Medics Ne is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Biotech Medics Ne has 172.36 M of shares currently outstending. This is 4.53% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 69.86% higher than that of the company.
Biotech Medics Ne Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotech Medics's current stock value. Our valuation model uses many indicators to compare Biotech Medics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotech Medics competition to find correlations between indicators driving Biotech Medics's intrinsic value. More Info.Biotech Medics Ne is number one stock in profit margin category among its peers. It also is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotech Medics' earnings, one of the primary drivers of an investment's value.About Biotech Medics Financial Statements
Biotech Medics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Biotech Medics investors may analyze each financial statement separately, they are all interrelated. The changes in Biotech Medics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Biotech Medics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
BioTech Medics, Inc. operates as a medical-based holding company. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida. Biotech Medics is traded on OTC Exchange in the United States.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biotech Pink Sheet Analysis
When running Biotech Medics' price analysis, check to measure Biotech Medics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Medics is operating at the current time. Most of Biotech Medics' value examination focuses on studying past and present price action to predict the probability of Biotech Medics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Medics' price. Additionally, you may evaluate how the addition of Biotech Medics to your portfolios can decrease your overall portfolio volatility.